Skip to main content
Top
Published in: Reactions Weekly 1/2024

01-01-2024 | Dexamethasone | Case report

Dexamethasone

Acanthosis Nigricans and secondary adrenal insufficiency

Published in: Reactions Weekly | Issue 1/2024

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Lai FY, et al. Acanthosis Nigricans in a Patient with Urothelial Carcinoma Treated with PD-L1 Inhibitor Avelumab, and Secondary Adrenal Insufficiency. Case Reports in Oncology 16 : 1107-1112, Oct 2023. Available from: URL: https://dx.doi.org/10.1159/000533758 Lai FY, et al. Acanthosis Nigricans in a Patient with Urothelial Carcinoma Treated with PD-L1 Inhibitor Avelumab, and Secondary Adrenal Insufficiency. Case Reports in Oncology 16 : 1107-1112, Oct 2023. Available from: URL: https://​dx.​doi.​org/​10.​1159/​000533758
Metadata
Title
Dexamethasone
Acanthosis Nigricans and secondary adrenal insufficiency
Publication date
01-01-2024
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-52594-1

Other articles of this Issue 1/2024

Reactions Weekly 1/2024 Go to the issue

Case report

Trastuzumab

Case report

Methotrexate